PATENT CLAIM ANALYSIS

Application Number: 16029166
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "210180"]

Abstract:
The present invention relates to inhibitors of bromo and extra terminal (BET) bromodomains that are useful for the treatment of cancer, inflammatory diseases, diabetes, and obesity, having Formula (I): wherein X, Y, Z, R 1 , R 2 , R 4  and R 7  are defined herein.

Claim (Index 8):
The compound of  claim 1 , wherein R 4  is phenyl, pyridine, pyridazine, pyrimidine or pyrazole.

Metadata:
- Claim Count in Document: 83.0
- Percentile: 95.0
- Lexical Diversity: 1.39535
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14546896', '14546775', '15937271', '14982127', '14720323']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.812684400063161
- 35 USC 102 Novelty (BERT): 0.6767976280571948
- Combined Prediction Score: 0.7990957228625645
- Mean Citation Score: 459.830116
- Max Citation Score: 708.1897
- Similarity Product: 680.8432584809483

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test